shLDH-A and control B16-F10 melanoma cells were injected subcutaneously into syngeneic C57BL/6 mice and each group was divided into two subsets, which were treated either with the anti-PD-1 antibody or an isotype control. Here, PDCD1 is linked to melanoma.